Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected Children

Completed · Phase 1/Phase 2

Conditions studied: HIV Infections

In brief

Limited data exist about combination anti-HIV treatment regimens in children, including how those drugs are cleared by the body in children. The purpose of this study is to measure the blood levels of the following combinations of anti-HIV drugs in HIV infected chilren: tenofovir disoproxil fumurate (TDF) and efavirenz (EFV) or nevirapine (NVP); TDF and darunavir (DRV) with or without EFV; and TDF and ritonavir (RTV) with or without EFV.

Key facts

Study ID
NCT00260078
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
People needed
75
Starts
2006-02-01
Expected to finish
2009-04-01
Last updated by the study team
2021-11-09

Who can join

Age: 8 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.